Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling evidence for the causal role of telomere shortening as a primary modifier of disease is that families with mutant telomerase genes display genetic anticipation39,83.”
From The telomere syndromes (2012) · cites this paper as [83]
In the citing paper
“Telomere length is influenced by many different factors, including age (13, 14) and the number of generations the mutation is transmitted (6, 15).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [15]
Citations
Cites
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationDyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Self-citationExtensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570
Function and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467
Structure and polymorphism of human telomere-associated DNA
Brown, W. R. A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J., & Dobson, M. J. (1990) · Cell · doi:10.1016/0092-8674(90)90293-n · Cited by 375
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 279
Self-citation
Cited by
Items 101–200 of 456
Engineered telomere degradation models dyskeratosis congenita
Hockemeyer, D., Palm, W., Wang, R. C., Couto, S. S., & de Lange, T. (2008) · Genes & Development · doi:10.1101/gad.1679208 · Cited by 116
“A telomere-based disease mechanism is consistent with the generational anticipation observed for DC (Vulliamy et al. 2004; Armanios et al. 2005), since affected parents are expected to contribute shorter telomeres to the next generation.”
BackgroundSenescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Owens, W. A., Walaszczyk, A., Spyridopoulos, I., Dookun, E., & Richardson, G. D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111540 · Cited by 122
“…insult and with the presence of a patent blood supply, CM regeneration may be sufficient to maintain tissue integrity and function, explaining the observed cardio-beneficial effects of senotherapies in aged mice (Anderson et al., 2019; Lewis-McDougall et al., 2019; Walaszczyk et al., 2019).”
BackgroundInfluentialde Leon, A. D., Cronkhite, J. T., Yılmaz, C., Brewington, C. C., Wang, R. C., Xing, C., Hsia, C. C. W., & Garcia, C. K. (2011) · CHEST Journal · doi:10.1378/chest.10-2865 · Cited by 116
Kirwan, M., Vulliamy, T., Marrone, A., Walne, A. J., Beswick, R., Hillmen, P., Kelly, R., Stewart, A., Bowen, D., Schonland, S. O., et al. (2009) · Human Mutation · doi:10.1002/humu.21115 · Cited by 109
“In these families, the heterozygous parent was often found to be asymptomatic, and it has been suggested that disease anticipation is occurring, associated with progressive telomere shortening through the generations [Vulliamy et al., 2004].”
BackgroundSelf-citationTelomeres and immunological diseases of aging.
Andrews, N. P., Fujii, H., Goronzy, J. J., & Weyand, C. M. (2010) · Gerontology · doi:10.1159/000268620 · Cited by 108
“is characterized by disease anticipation in carrier families linked to an increased loss of telomere sequences in succeeding generations [”
BackgroundLansdorp, P. M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.172 · Cited by 108
Aston, K. I., Hunt, S. C., Susser, E., Kimura, M., Factor-Litvak, P., Carrell, D., & Aviv, A. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas028 · Cited by 108
Beyond average: potential for measurement of short telomeres
Vera, E., & Blasco, M. A. (2012) · Aging · doi:10.18632/aging.100462 · Cited by 109
“This association is supported by the fact that the rate of telomere shortening with aging is accelerated in some premature aging syndromes owe to mutations in telomerase such as some cases of Dyskeratosis congenita (DC) or aplastic anemia [48, 49].”
BackgroundThe Genetic Basis of Natural Variation in Caenorhabditis elegans Telomere Length
Cook, D. E., Zdraljevic, S., Tanny, R. E., Seo, B., Riccardi, D., Noble, L. M., Rockman, M. V., Alkema, M. J., Braendle, C., Kammenga, J. E., et al. (2016) · Genetics · doi:10.1534/genetics.116.191148 · Cited by 118
“However, differences in telomere length caused by mutations in genes that encode telomere-associated proteins often do not have observable telomere defects for a number of generations (Vulliamy et al. 2004; Armanios et al. 2005; Marrone et al. 2005).”
BackgroundMethodThe effect of TERC haploinsufficiency on the inheritance of telomere length
Goldman, F., Bouarich, R., Kulkarni, S., Freeman, S., Du, H.-Y., Harrington, L., Mason, P. J., Londoño-Vallejo, A., & Bessler, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505318102 · Cited by 106
Self-citationXin, Z.-T., Beauchamp, A. D., Calado, R. T., Bradford, J. W., Regal, J. A., Shenoy, A., Liang, Y., Lansdorp, P. M., Young, N. S., & Ly, H. (2007) · Blood · doi:10.1182/blood-2006-07-035089 · Cited by 107
Mendelian inheritance revisited: dominance and recessiveness in medical genetics
Zschocke, J., Byers, P. H., & Wilkie, A. O. M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00574-0 · Cited by 127
Inherited Predisposition to Acute Myeloid Leukemia
Godley, L. A. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.08.001 · Cited by 111
“Both TERT and TERC mutations are associated with anticipation, with progressively shorter telomeres with successive generations.(83) Members of older generations often demonstrate mild disease, whereas younger patients experience more severe disease manifestations, such as aplastic anemia or MDS/AML.”
BackgroundVulliamy, T. J., Kirwan, M. J., Beswick, R., Hossain, U., Baqai, C., Ratcliffe, A., Marsh, J., Walne, A., & Dokal, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024383 · Cited by 105
“disease anticipation associated with telomere shortening in families with TERC and TERT mutations [17,40,41], shorter telomeres among patients with TINF2 mutations [42], and patients with severe disease caused by DKC1 mutations having shorter telomeres than those with mild disease [43].”
BackgroundSelf-citationNothobranchius furzeri: A Model for Aging Research and More
Platzer, M., & Englert, C. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.06.006 · Cited by 116
Telomere and adaptive immunity
Weng, N.-P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.005 · Cited by 99
“In the X-linked form of DC, the gene involved encodes dyskerin, a protein that is involved in telomerase RNP assembly (Mitchell et al., 1999), while in the autosomal form of DC, there are mutations in the TERC and TERT genes (Vulliamy et al., 2004; Walne et al., 2007; Marrone et al., 2007).”
He, H., Wang, Y., Guo, X., Ramchandani, S., Ma, J., Shen, M.-F., Garcia, D. A., Deng, Y., Multani, A. S., You, M. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01400-08 · Cited by 101
“In addition, DC families bearing mutations in hTert and hTerc show progressive telomere shortening with each generation and a disease anticipation phenotype consistent with telomerase haploinsufficiency (1, 5, 24, 34).”
BackgroundTelomere Dynamics in Macaques and Humans
Gardner, J. P., Kimura, M., Chai, W., Durrani, J. F., Tchakmakjian, L., Cao, X., Lu, X., Li, G., Peppas, A. P., Skurnick, J., et al. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.4.367 · Cited by 97
“From this perspective, the telomerase knock-out mouse (11,31), for instance, is not strictly a model of aging but of diseases such as dyskeratosis congenita (32).”
BackgroundBrümmendorf, T. H., & Balabanov, S. (2006) · Leukemia · doi:10.1038/sj.leu.2404339 · Cited by 104
Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer
Martinez-Delgado, B., Yanowsky, K., Inglada-Perez, L., Domingo, S., Urioste, M., Osorio, A., & Benitez, J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002182 · Cited by 93
“Telomere shortening has been more recently described as another mechanism of anticipation, being associated with early onset and severity of disease in genetic disorders, such as dyskeratosis congenita [12,13], a disease characterized by cutaneous abnormalities, bone marrow failure and an increased predisposition to c…”
BackgroundDiagnosis of Fanconi Anemia by Diepoxybutane Analysis
Auerbach, A. D. (2015) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0807s85 · Cited by 106
Savage, S. A., & Dufour, C. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.004 · Cited by 95
Mechanisms of non-Mendelian inheritance in genetic disease
van Heyningen, V., & Yeyati, P. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh254 · Cited by 105
“Anticipation is also reported in dyskeratosis congenita where the underlying mutation is in the RNA component of telomerase (TERC ), and the increasing disease severity through the generations is imposed through the co-inheritance of the TERC mutation with the progressively shortened telomere length (96).”
BackgroundOral and dental phenotype of dyskeratosis congenita
Atkinson, J., Harvey, K., Domingo, D., Trujillo, M., Guadagnini, J. P., Gollins, S., Giri, N., Hart, T., & Alter, B. (2007) · Oral Diseases · doi:10.1111/j.1601-0825.2007.01394.x · Cited by 87
Capezzone, M., Cantara, S., Marchisotta, S., Filetti, S., Santi, M. M. D., Rossi, B., Ronga, G., Durante, C., & Pacini, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0372 · Cited by 97
Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation
Aix, E., Gutiérrez-Gutiérrez, Ó., Sánchez-Ferrer, C., Aguado, T., & Flores, I. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510091 · Cited by 84
“In contrast, some individuals from families with premature telomere shortening suffer from dilated cardiomyopathy, severe cardiac fibrosis, and myocardial infarction at young ages (Vulliamy et al., 2004; Basel-Vanagaite et al., 2008), and humans with genetic variants affecting telomere length are at above-average risk…”
Functional characterization of telomerase RNA variants found in patients with hematologic disorders
Ly, H., Calado, R. T., Allard, P., Baerlocher, G. M., Lansdorp, P. M., Young, N. S., & Parslow, T. G. (2005) · Blood · doi:10.1182/blood-2004-09-3659 · Cited by 85
Knudson, M., Kulkarni, S., Ballas, Z. K., Bessler, M., & Goldman, F. (2005) · Blood · doi:10.1182/blood-2004-04-1673 · Cited by 82
Kam, M. L. W., Nguyen, T. T. T., & Ngeow, J. Y. Y. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00198-5 · Cited by 96
Genetic determinants of pulmonary fibrosis: evolving concepts
Spagnolo, P., Grünewald, J., & du Bois, R. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70047-5 · Cited by 89
A Dual Role of p21 in Stem Cell Aging
Ju, Z., Choudhury, A. R., & Rudolph, K. L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.036 · Cited by 92
Bessler, M., Wilson, D. B., & Mason, P. J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.019 · Cited by 81
Self-citationDyskeratosis Congenita: A historical perspective
Walne, A. J., & Dokal, I. S. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.006 · Cited by 93
Self-citationRobart, A. R., & Collins, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088575 · Cited by 89
Dyskerin Is a Component of the Arabidopsis Telomerase RNP Required for Telomere Maintenance
Kannan, K. P., Nelson, A. D. L., & Shippen, D. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01490-07 · Cited by 82
“Indeed, haploinsufficiency of hTR is directly linked to autosomal dominant DC, and the reduced hTR levels along with shorter telomeres in these patients result in disease anticipation (46).”
BackgroundPulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Molecular basis of telomere dysfunction in human genetic diseases
Sarek, G., Marzec, P., Margalef, P., & Boulton, S. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3093 · Cited by 89
Human Telomeres and Telomere Biology Disorders
Savage, S. A. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00002-5 · Cited by 81
Telomerase and Cancer Stem Cells
ARMANIOS, M., & GREIDER, C. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.030 · Cited by 76
The role of telomere biology in bone marrow failure and other disorders
Savage, S. A., & Alter, B. P. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.002 · Cited by 82
“Subsequently mutations were found in TERC in families with autosomal dominant inheritance (Vulliamy et al., 2004).”
BackgroundBaerlocher, G. M., Rice, K., Vulto, I., & Lansdorp, P. M. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2006.00254.x · Cited by 75
“telomerase levels resulting from haploinsufficiency for either the telomerase RNA gene TERC ( Vulliamy et al ., 2004 ) or the telomerase reverse transcriptase gene TERT (Yamaguchi et al ., 2005) can both result in bone marrow failure.”
BackgroundPlunkett, F. J., Franzese, O., Belaramani, L. L., Fletcher, J. M., Gilmour, K. C., Sharifi, R., Khan, N., Hislop, A. D., Cara, A., Salmon, M., et al. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.03.006 · Cited by 74
Gu, P., & Chang, S. (2013) · Aging Cell · doi:10.1111/acel.12139 · Cited by 73
“Autosomal dominant and recessive forms of this disease are due to mutations in hTERC and hTERT, respectively (Vulliamy et al., 2001, 2004), while X-linked DC is a result of mutations in Dyskerin (DC1), a small nuclear RNA–binding protein that interacts with TERC and is required for telomerase…”
BackgroundDefective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs
Winkler, T., Hong, S. G., Decker, J. E., Morgan, M. J., Wu, C., Hughes, W. M., Yang, Y., Wangsa, D., Padilla-Nash, H. M., Ried, T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67146 · Cited by 72
“In families with TERT or TERC heterozygous mutations, clinical features may manifest earlier and with greater severity in each subsequent generation, a phenomenon termed disease anticipation (38).”
Martínez, P., & Blasco, M. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312202 · Cited by 82
The biology and management of dyskeratosis congenita and related disorders of telomeres
Tummala, H., Walne, A. J., & Dokal, I. S. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2108784 · Cited by 75
“This phenomenon of genetic anticipation adds complexity to making prognostic predictions [22,23].”
BackgroundSelf-citationThe genetics of interstitial lung diseases
Borie, R., Guen, P. L., Ghanem, M., Taillé, C., Dupin, C., Dieudé, P., Kannengiesser, C., & Crestani, B. (2019) · European Respiratory Review · doi:10.1183/16000617.0053-2019 · Cited by 79
Dyskeratosis congenita: a literature review
Alsabbagh, M. M. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14268 · Cited by 91
Marrone, A., Sokhal, P., Walne, A., Beswick, R., Kirwan, M., Killick, S., Williams, M., Marsh, J., Vulliamy, T., & Dokal, I. (2007) · Haematologica · doi:10.3324/haematol.11407 · Cited by 67
“This feature has not been previously described in TERC families, in which disease anticipation has been observed.(10) One possible explanation of this new phenomenon was that these particular TERC mutations exerted a dominant-negative effect on telomerase activity.”
BackgroundSelf-citationControl of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres
Roake, C. M., & Artandi, S. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026088 · Cited by 67
“DC can become more severe and present at an earlier age in the children of patients as telomeres shorten from generation to generation, just as in telomerase knockout mice (Vulliamy et al. 2004; Armanios et al. 2005).”
BackgroundSiegl-Cachedenier, I., Flores, I., Klatt, P., & Blasco, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704141 · Cited by 64
“…reduced telomerase activity caused by mutations in telomerase components in the human diseases dyskeratosis congenita (Mitchell et al., 1999; Vulliamy et al., 2001, 2004; Mason et al., 2005), aplastic anemia (Marrone et al., 2004; Yamaguchi et al., 2005), and idiopathic pulmonary fi brosis…”
Triallelic and epigenetic-like inheritance in human disorders of telomerase
Collopy, L. C., Walne, A. J., Cardoso, S., de la Fuente, J., Mohamed, M., Toriello, H., Tamary, H., Ling, A. J. Y. V., Lloyd, T., Kassam, R., et al. (2015) · Blood · doi:10.1182/blood-2015-03-633388 · Cited by 63
“Although TERC andTERT variants are associatedwith a number of disease phenotypes, the investigation of telomerase variants is further complicated by variable penetrance within families, late onset of disease, subclinical features, anddisease anticipationdue to progressive telomere shortening through successive generat…”
BackgroundSelf-citationNovel roles for telomerase in aging
Geserick, C., & Blasco, M. A. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.017 · Cited by 79
Telomeres, senescence, and hematopoietic stem cells
Zimmermann, S., & Martens, U. M. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0469-4 · Cited by 72
“Haploinsufficiency of hTERC most likely results in an anticipation of autosomal dominant DKC disease forms correlated with an increase in telomere shortening in successive generations of affected families (Vulliamy et al. 2004).”
BackgroundTIN2 Protein Dyskeratosis Congenita Missense Mutants Are Defective in Association with Telomerase
Yang, D., He, Q., Kim, H., Ma, W., & Songyang, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225870 · Cited by 79
Recognizing familial myeloid leukemia in adults
Nickels, E. M., Soodalter, J. A., Churpek, J. E., & Godley, L. A. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620713487399 · Cited by 79
“Both TERT and TERC mutations are associated with anticipation, with progressively shorter telomeres passed down through generations [Vulliamy et al. 2004].”
BackgroundTelomeres and Telomerase in the Control of Stem Cells
Lupatov, A. Y., & Yarygin, K. N. (2022) · Biomedicines · doi:10.3390/biomedicines10102335 · Cited by 67
Telomere dysfunction and its role in haematological cancer
Jones, C. H., Pepper, C. J., & Baird, D. M. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09022.x · Cited by 67
“…aplastic anaemia have been shown to have shortened TL that is attributed to mutations in telomere associated genes such as DKC1, TERC, TERT and TINF2 in DC and TERC, TERT and TERF1 in acquired aplastic anaemia (Vulliamy et al, 2002, 2004, 2005, 2008; Yamaguchi et al, 2003, 2005; Walne et al, 2008).”
BackgroundZhang, D., & Newton, C. A. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.037 · Cited by 72
Du, H.-Y., Pumbo, E., Manley, P., Field, J. J., Bayliss, S. J., Wilson, D. B., Mason, P. J., & Bessler, M. (2008) · Blood · doi:10.1182/blood-2007-10-120907 · Cited by 60
“In contrast to patients with X-linked DC, who usually develop severe disease with a high penetrance, disease penetrance and expressivity in AD DC are highly variable and, in addition to the gene mutation, the inheritance of short telomeres is required for the manifestation of the disease.(7,8) Here we demonstrate that…”
Self-citationBenyelles, M., O’Donohue, M.-F., Kermasson, L., Lainey, E., Borie, R., Lagresle-Peyrou, C., Nunes, H., Cazelles, C., Fourrage, C., Ollivier, E., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa011 · Cited by 58
Telomere length inheritance and aging
Kappei, D., & Londoño‐Vallejo, A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.009 · Cited by 63
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice
Frescas, D., & de Lange, T. (2014) · Genes & Development · doi:10.1101/gad.233395.113 · Cited by 68
“keeping with the generational disease anticipation observed in DC (Vulliamy et al. 2004).”
BackgroundRegulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 69
“characterized by accelerated telomere shortening [239, 246].”
Tümpel, S., & Rudolph, K. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06547.x · Cited by 54
Trková, M., Procházková, K., Krutilkova, V., Sumerauer, D., & Sedláček, Z. (2007) · Cancer · doi:10.1002/cncr.22834 · Cited by 61
“Haploinsufficiency of TERC causes progressive telomere shortening in DC.(7)”
BackgroundInfluentialAubert, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00004-9 · Cited by 62
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Goldman, F. D., Aubert, G., Klingelhutz, A. J., Hills, M., Cooper, S. R., Hamilton, W. S., Schlueter, A. J., Lambie, K., Eaves, C. J., & Lansdorp, P. M. (2008) · Blood · doi:10.1182/blood-2007-10-120204 · Cited by 54
Balogh, E., Chandler, J. C., Varga, M., Tahoun, M. M., Menyhárd, D. K., Schay, G., Goncalves, T., Hamar, R., Légrádi, R., Szekeres, Á., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002328117 · Cited by 57
“Indeed, progressive telomere attrition in the autosomal-dominant TERT- or TERC-related DC results in disease anticipation (15, 16), and wild-type (WT) offspring of telomerase-deficient mice with shortened telomeres develop an occult DC phenotype (17).”
BackgroundHuman telomerase expression regulation
Machnik, M., Wojtyla, A., & Rubiś, B. (2011) · Biochemistry and Cell Biology · doi:10.1139/o11-037 · Cited by 62
“…gene cause short telomeres in congenital aplastic anemia of dyskeratosis congenita (DKC) and in some cases of apparently acquired aplastic anemia (Vulliamy et al. 2001; Comolli et al. 2002; Fogarty et al. 2003; Theimer et al. 2003; Vulliamy et al. 2004; Goldman et al. 2005; Yamaguchi et al. 2005).”
BackgroundGenetic Interstitial Lung Disease
Devine, M., & Garcia, C. K. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.11.001 · Cited by 58
Zhang, Y., Wu, Y., Mao, P., Li, F., Han, X., Zhang, Y., Jiang, S., Chen, Y., Huang, J., Liu, D., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1465 · Cited by 60
Dyskeratosis Congenita: A Disorder of Defective Telomere Maintenance?
Walne, A. J., Marrone, A., & Dokal, I. S. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05067 · Cited by 54
“A recent study by Vulliamy et al [ 53 ] has also demonstrated that patients with AD-DC exhibit the phenomenon known as disease anticipation (the onset of disease at a progressively younger age in successive generations).”
ResultSelf-citationThe clinical and functional effects of TERT variants in myelodysplastic syndrome
Reilly, C. R., Myllymäki, M., Redd, R., Padmanaban, S., Karunakaran, D., Tesmer, V., Tsai, F. D., Gibson, C. J., Rana, H. Q., Zhong, L., et al. (2021) · Blood · doi:10.1182/blood.2021011075 · Cited by 51
Bartocci, C., Diedrich, J. K., Ouzounov, I., Li, J., Piunti, A., Pasini, D., Yates, J. R., & Lazzerini Denchi, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.002 · Cited by 49
“…disease is caused by mutations affecting either telomere elongation factors (dyskerin and hTERT) or telomere-associated proteins (Dokal, 2000; Kirwan and Dokal, 2009; Mitchell et al., 1999; Sarper et al., 2010; Shay and Wright, 1999; Touzot et al., 2010; Vulliamy et al., 2004; Walne et al., 2008).”
BackgroundEvaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita
Agarwal, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.04.003 · Cited by 52
Leukocyte Telomere Length Is Associated with Disability in Older U.S. Population
Risques, R. A., Arbeev, K. G., Yashin, A. I., Ukraintseva, S. V., Martin, G. M., Rabinovitch, P. S., & Oshima, J. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02948.x · Cited by 48
Translational research in pulmonary fibrosis
Mathai, S. K., & Schwartz, D. A. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.001 · Cited by 53
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia
Savage, S. A., Calado, R. T., Xin, Z.-T., Ly, H., Young, N. S., & Chanock, S. J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.008 · Cited by 47
“Autosomal dominant DKC has been shown to result from mutations in the TERC gene, which encodes the RNA component of the telomerase complex that serves as a template for telomere elongation [6].”
BackgroundHeterogeneous telomere defects in patients with severe forms of dyskeratosis congenita
Touzot, F., Gaillard, L., Vasquez, N., Guen, T. L., Bertrand, Y., Bourhis, J., Leblanc, T. M., Fischer, A., Soulier, J., de Villartay, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.043 · Cited by 53
Telomere Dysfunction, Chromosomal Instability and Cancer
Meena, J. K., Rudolph, K. L., & Güneş, Ç. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_3 · Cited by 61
Basel-Vanagaite, L., Dokal, I., Tamary, H., Avigdor, A., Garty, B. Z., Volkov, A., & Vulliamy, T. (2008) · Haematologica · doi:10.3324/haematol.12317 · Cited by 48
“Death was due to respiratory failure or hepatic failure; one patient died as a result of myocardial infarction, a complication that has been noted once previously in AD DC in a TERC heterozygote.(4) No malignancies were observed.”
BackgroundSelf-citationMechanisms driving the ageing heart
Anderson, R., Richardson, G. D., & Passos, J. F. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.015 · Cited by 46
Telomerase RNA processing: Implications for human health and disease
Nagpal, N., & Agarwal, S. (2020) · Stem Cells · doi:10.1002/stem.3270 · Cited by 48
Mechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
Mutations in telomerase catalytic protein in Japanese children with aplastic anemia.
Liang, J. B., Yagasaki, H., Kamachi, Y., Hama, A., Matsumoto, K., Kato, K., Kudo, K., & Kojima, S. (2006) · PubMed · Cited by 50
Bagby, G. C., Lipton, J. M. M., Sloand, E. M., & Schiffer, C. A. (2004) · Hematology · doi:10.1182/asheducation-2004.1.318 · Cited by 45
Lechel, A., Manns, M. P., & Rudolph, K. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.010 · Cited by 47
“[36] Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I.”
BackgroundLamm, N., Elly, O., Shponkin, R., Richler, C., Aker, M., & Tzfati, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005666 · Cited by 49
“: G3) raised the possibility of paternal transmission of a mutation associated with the disease from G1 to P1 and to S2–5. We considered the possibility of paternal autosomal-dominant inheritance accompanied by anticipation – the aggravation of the disease phenotype in successive generations due to progressively short…”
ResultFernandes, S. G., Dsouza, R., & Khattar, E. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103633 · Cited by 47
Telomere biology and translational research
Mason, P. J., & Perdigones, N. (2013) · Translational research · doi:10.1016/j.trsl.2013.08.009 · Cited by 45
“by Grammatges and Bertush (26) a feature of the autosomal forms of the disease is that they show anticipation, with the disease becoming more severe, and the age of onset lower, in succeeding generations (27) This is almost certainly because children of affected parents inherit shortened telomeres as well as the mutat…”
BackgroundSelf-citationTelomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 52
Gupta, V. K., Gordon‐Smith, E. C., Cook, G., Parker, A. N., Duguid, J. K. M., Wilson, K. M. O., Yi, Q., & Marsh, J. C. W. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05406.x · Cited by 41
“Recently, it has been shown that some of the apparently ‘acquired’ AA patients have mutations at the telomerase RNA gene (TERC) and telomerase reverse transcriptase (TERT) gene (Fogarty et al, 2003; Calado et al, 2004; Vulliamy et al, 2004).”
BackgroundAscertainment Bias Causes False Signal of Anticipation in Genetic Prion Disease
Minikel, E. V., Zerr, I., Collins, S. J., Ponto, C., Boyd, A., Klug, G. M., Karch, A., Kenny, J., Collinge, J., Takada, L. T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.09.003 · Cited by 44
“The only genetic mechanisms known to cause anticipation are the germline expansion of unstable repeats in disorders such as Huntington’s disease and type 1 myotonic dystrophy,(15,16) and telomere shortening in disorders such as dyskeratosis congenita and breast cancer.(17,18) Anticipation in a genetic prion disease mi…”
BackgroundA Common Variant in the Telomerase RNA Component Is Associated with Short Telomere Length
Njajou, O. T., Blackburn, E. H., Pawlikowska, L., Mangino, M., Damcott, C. M., Kwok, P.-Y., Spector, T. D., Newman, A. B., Harris, T. B., Cummings, S. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013048 · Cited by 41
“Mutations in TERC result in a reduction of telomerase activity leading to premature telomere shortening and have been linked to the autosomal dominant form of dyskeratosis congenita and aplastic anemia [5,6].”
BackgroundThe wide-ranging clinical implications of the Short Telomere Syndromes
Barbaro, P. M., Ziegler, D. S., & Reddel, R. R. (2016) · Internal Medicine Journal · doi:10.1111/imj.12868 · Cited by 40
Hills, M., & Lansdorp, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04565.x · Cited by 40
Telomere dysfunction and stem cell ageing
Ju, Z., & Rudolph, K. L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.006 · Cited by 48
Alcaraz‐Pérez, F., García‐Castillo, J., García‐Moreno, D., López‐Muñoz, A., Anchelin, M., Angosto-Bazarra, D., Zon, L. I., Mulero, V., & Cayuela, M. L. (2014) · Nature Communications · doi:10.1038/ncomms4228 · Cited by 42
Metadata
- Authors
- Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I.
- Affiliations
- Hammersmith Hospital (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Mason, Philip J
- Venue
- Nature Genetics
- Published
- 2004-04-18
- Volume
- 36
- Issue
- 5
- Pages
- 447-449
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2025843494
- Cited by
- 461
- References
- 15
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 16 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 15 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- dyskeratosis congenita, telomere shortening, TERC mutations, telomerase RNA, telomerase, bone marrow failure, autosomal dominant inheritance
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Family, Female, Genes, Dominant, Humans, Male, Middle Aged, Mutation, Pedigree, RNA, Telomere, Sequence Deletion, Telomerase, Dyskeratosis Congenita
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.